Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
07/2007
07/04/2007CN1990046A Macromolecule micelle with positive charge and forming method thereof
07/04/2007CN1990042A SARS coronary virus resistant cell vaccine and its uses
07/04/2007CN1324136C SiRNA double chain for inhibiting bc 1-2 gen expression and use
07/04/2007CN1323723C Tie2 receptor mediated gene transfer system for targeted tumor gene therapy
07/04/2007CN1323716C Use of SAPR-1 for the treatment and/or prevention of scleroderma
07/03/2007US7238851 Non-human transgenic mammals expressing an n-3 desaturase gene
07/03/2007US7238796 Oncogenic protein for use in diagnosis, prevention and treatment of cell proliferative disorders of nervous ystem
07/03/2007US7238795 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses
07/03/2007US7238675 consisting of a substantially uncharged antisense oligomer with ratio of uncharged linkages to charged linkages in the oligomer is at least 4:1, preferably at least 5:1, and more preferably at least 8:1
07/03/2007US7238674 In situ injection; transduction; sustained release
07/03/2007US7238673 Genetic enginnering; kits
07/03/2007US7238528 Means and methods for fibroblast-like or macrophage-like cell transduction
07/03/2007US7238526 Methods and cell line useful for production of recombinant adeno-associated viruses
07/03/2007US7238525 Inhibition of Bcr-Abl oncoprotein expression in cytoplasm by inducing translocation to the nucleus to activate the apoptotic pathway in cancer cells
07/03/2007US7238356 Core-glycosylated HCV envelope proteins
07/03/2007US7238352 Methods and compositions for modulating tumor growth
07/03/2007US7238347 Use of a mutant Leishmania responsive to external signals such as red or white light to become porphyric and commit suicidal cytolysis, immunizing a mammal
07/03/2007US7238346 An Ad5 left terminus, a promoter, a Factor VIII cDNA wherein the B- domain has been deleted; and an Ad5 right terminus.
07/03/2007CA2333465C Growth differentiation factor promoter and uses therefor
07/03/2007CA2319096C Method for treating acute intermittent porphyria (aip) and other porphyric diseases
07/03/2007CA2295199C Method for treating vascular proliferative diseases with p27 and fusions thereof
07/03/2007CA2174122C Therapeutic delivery compositions and methods of use thereof
07/03/2007CA2158869C Recombinant virus, process for preparing the same and use thereof in gene therapy
07/03/2007CA2092567C Nt-4 neurotrophic factor
06/2007
06/28/2007WO2007072977A1 Pharmaceutical composition for allergic disease
06/28/2007WO2007072909A1 NOVEL OLIGONUCLEOTIDE AND NF-κB DECOY COMPRISING THE SAME
06/28/2007WO2007072866A1 Anti-ilt7 antibody
06/28/2007WO2007071994A2 Viral vectors
06/28/2007WO2007071454A2 Dendritic cell specific transcription regulator dc-script and uses thereof
06/28/2007WO2007071069A1 Transcription factor decoy oligodeoxynucleotides having multiple cis elements
06/28/2007WO2007071053A1 Markers for memory t cells and uses thereof
06/28/2007WO2007014029A3 Yin yang 1 as a treatment for cardiac hypertrophy and heart failure
06/28/2007WO2006130560A3 Manipulation of pten in t cells as a strategy to modulate immune responses
06/28/2007WO2006121464A3 Compositions for treating respiratory viral infections and their use
06/28/2007WO2006119341A3 Gene therapy for spinal cord disorders
06/28/2007WO2005072419A3 Gastrointestinal proliferative factor and uses thereof
06/28/2007WO2002083919A3 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
06/28/2007US20070150972 Method for detecting Nipah virus and method for providing immunoprotection against Henipa viruses
06/28/2007US20070150971 Sequences upstream of the carp gene, vectors containing them and uses thereof
06/28/2007US20070149770 Poly zinc finger proteins with improved linkers
06/28/2007US20070149769 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
06/28/2007US20070149475 AUGMENTATION OF WOUND HEALING BY eIF-4E mRNA AND EGF mRNA
06/28/2007US20070149474 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
06/28/2007US20070149473 RNAi-mediated inhibition of RHO kinase for treatment of ocular disorders
06/28/2007US20070149472 Oligonucleotide for controlling gene expression of kinase ;anticancer agents; antitumor agents
06/28/2007US20070149471 Gene expression inhibition using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR; diabetic retinopathy, age related macular degeneration and many types of cancer
06/28/2007US20070149470 Inhibition of viral gene expression using small interfering RNA
06/28/2007US20070149469 Medical use of tbk-1 or of inhibitors thereof
06/28/2007US20070149468 Methods and compositions for rna interference
06/28/2007US20070149467 vascular endothelial growth factor (VEGF); ischemic heart disease
06/28/2007US20070149455 Modified and stabilized gdf propeptides and uses thereof
06/28/2007US20070149453 Treating inflammation using a biological agent that causes cells to release cytokine receptors
06/28/2007US20070148734 Hyaluronic acid mediated adenoviral transduction
06/28/2007US20070148706 Pancreatic progenitor cells and methods for isolating the same
06/28/2007US20070148692 KCNQ potassium channels and methods of modulating same
06/28/2007US20070148688 Novel human enzymes of the metalloprotease family
06/28/2007US20070148682 Protein fragment complementation assays for the detection of biological or drug interactions
06/28/2007US20070148663 recombinant nucleic acid which when introduced in vivo into a mammalian cell endogenously expressing EB1, inhibits the expression of EB1 therein, thereby reducing the amount of stable microtubules in the cell; antinflammatory agents
06/28/2007US20070148629 Composition for the preservation of viruses
06/28/2007US20070148179 Gankyrin
06/28/2007US20070148175 Diagnostics and therapeutics for diseases associated with kallikrein 12 (klk12)
06/28/2007US20070148173 Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of Alpha V Beta 6
06/28/2007US20070148172 Method for the treatment of inflammatory bowel disease
06/28/2007US20070148145 identifying therapeutically responsive phenotype in brain tumor cells by measuring expression of TNFAIP3 gene (tumor necrosis factor alpha-induced protein 3)
06/28/2007US20070148144 Gene-enhanced tissue engineering
06/28/2007US20070148134 A siRNA sequence against the constant region of the influenza virus nucleoprotein gene adapted to express intercellularly and establish a permanent inhibitory effect against influenza virus by integrating to the cellular chromosome of animals including humans
06/28/2007US20070148133 Potent inhibition of influenza virus by specifically designed short interfering RNA
06/28/2007US20070148132 Nervous system disorder; includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system; tightly regulatable gene delivery vector
06/28/2007US20070148131 Methods and compositions for needleless delivery of binding partners
06/28/2007US20070148130 Native TRRE: protein implicated in TNF receptor shedding for treating arthritis and inflammation
06/28/2007CA2634291A1 Transcription factor decoy oligodeoxynucleotides having multiple cis elements
06/28/2007CA2634116A1 Anti-ilt7 antibody
06/28/2007CA2634072A1 Markers for memory t cells and uses thereof
06/28/2007CA2633793A1 Methods of clustering gene and protein sequences
06/27/2007EP1801219A2 Neisserial antigenic peptides
06/27/2007EP1801209A1 Modified human hepatitis c virus genomic rna having autonomous replicative competence
06/27/2007EP1801204A1 Recombinant herpesvirus of turkeys and uses thereof
06/27/2007EP1800697A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas
06/27/2007EP1800670A1 Micellar drug delivery systems for hydrophobic drugs
06/27/2007EP1800289A1 Single -pass image warping system and mehtod with anisotropic filtering
06/27/2007EP1799836A2 Improved adenoviral vectors and uses thereof
06/27/2007EP1799834A1 Conditional gene vectors regulated in cis
06/27/2007EP1799833A1 Enhanced zein reduction in transgenic corn seed
06/27/2007EP1799748A1 Biodegradable cationic polymers
06/27/2007EP1799701A2 Peptide inhibitors of hk2 and their use.
06/27/2007EP1799272A2 Promotion of cell migration and axon regeneration in the cns
06/27/2007EP1799271A2 Delivery of polynucleotides
06/27/2007EP1799270A2 Compositions and methods for inhibiting expression of anti-apoptotic genes
06/27/2007EP1799247A1 Method for diagnosing and treating bone-related diseases
06/27/2007EP1799243A2 Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway
06/27/2007EP1492570A4 Method of diagnosis and treatment of breast lesions
06/27/2007EP1121436B1 Non-desensitizing ampa-receptors
06/27/2007EP0981549B2 Use of an inhibitor substance for the improvement of neuronal regeneration
06/27/2007EP0845043B1 Transport proteins and their uses
06/27/2007CN1989250A Tc-83-derived alphavirus vectors, particles and methods
06/27/2007CN1986810A Japanese blood fluke epiderm antigen and candidate vaccine gene and pretin and their application
06/27/2007CN1986809A Japanese blood fluke epiderm antigen gene and protein and their application
06/27/2007CN1986801A Japanese blood fluke specific epiderm antigen gene and protein and their application
06/27/2007CN1986800A Japanese blood fluke specific epiderm antigen gene and its coded protein and application
06/27/2007CN1986799A Japanese blood fluke epidermal gene and its coded protein and application